Welcome to our dedicated page for Iperionx news (Ticker: IPX), a resource for investors and traders seeking the latest updates and insights on Iperionx stock.
IperionX Limited (IPX) generates frequent news coverage through its role as an American titanium metal and critical materials company focused on building a U.S. mineral-to-metal titanium supply chain. Company announcements highlight progress at its Titanium Manufacturing Campus in Virginia, where titanium powder production, powder metallurgy and forging systems have been commissioned and are being scaled, as well as developments at the Titan Critical Minerals Project in Tennessee.
News items often detail new contracts, task orders and partnerships. IperionX has reported a SBIR Phase III Indefinite Delivery, Indefinite Quantity contract with a ceiling of up to US$99 million, enabling U.S. Government agencies to place task orders for titanium components. It has announced its first U.S. Army task order for titanium parts for ground vehicle programs, and a project with Carver Pump Company to prototype titanium components for U.S. Navy pump systems using its domestically produced titanium powder and in-house manufacturing capabilities.
Investors following IPX news will also see updates on U.S. Department of Defense and Department of War funding under the Industrial Base Analysis and Sustainment program, Defense Production Act Title III support, and other awards that back expansion of titanium capacity in Virginia and advancement of the Titan Critical Minerals Project. Quarterly reports provide additional context on production milestones, customer programs in defense, aerospace, automotive and consumer electronics, and the evolution of IperionX’s scrap feedstock strategy.
This news feed aggregates these disclosures, including press releases furnished on Form 6-K, funding announcements, commercial agreements, and operational updates. Readers can use it to track how IperionX’s titanium technologies, government-supported programs and customer partnerships progress over time.
IperionX (Nasdaq | ASX: IPX) will host a live investor webinar with Founder and CEO Taso Arima on Tue April 28, 2026 at 9:00 am AEST (Mon April 27, 2026 at 19:00 pm U.S. EDT). The event will be held via Zoom; registered attendees receive joining details by email.
Registration is required via the company’s webinar link and contacts for investors and media are provided.
IperionX (Nasdaq: IPX) reported March 31, 2026 quarterly results showing transition from commissioning to continuous 24/7 operations at its Virginia campus. Key metrics: HAMR™ powder reached ~4.2 metric tons in March (~50 tpa annualized), targeting ~200 tpa by end-CY2026, cash US$48.2M and US$42.1M obligated reimbursable funding.
U.S. Government support includes a US$47.1M IBAS award, ~290 t of scrap feedstock transferred, and SBIR Phase III IDIQ contracting pathway up to US$99M. GenX™ and Titan DFS progressed; downstream presses and HSPT™ furnaces are being commissioned to remove production bottlenecks.
IperionX (NASDAQ: IPX) announced filings on March 30, 2026 disclosing changes in directors' and officers' ownership. The filings list share and ADS purchases by executives: Anastasios Arima (467,000 shares; 12,800 ADS; US$1,331,787.84), Todd Hannigan (225,225 shares; US$498,225.95), R. Tony Tripeny (4,187 ADS; US$99,463.67) and Toby Symonds (11,000 ADS; US$262,552.40).
The release notes A$ amounts converted to US$ using the Reserve Bank of Australia rate on May 27, 2026 (0.6911). Contact emails for investor and media relations are provided.
IperionX (NASDAQ: IPX) CEO Taso Arima outlines 2026 priorities to scale a U.S. domestic titanium supply chain using proprietary HAMR™ and HSPT™ technologies now operating at commercial scale in Virginia. Key near-term milestones include a 7x expansion to ~1,400 tpa with commissioning targeted mid-2027 and a Definitive Feasibility Study for the 100% owned Titan Critical Minerals Project due in Q2 2026. The letter introduces GenX™, a continuous HAMR platform expected to reach commercial-scale validation in 2026 and support capital-efficient scaling through 2030.
The plan emphasizes operational excellence, lower unit costs via recycled scrap and domestic feedstocks, and supplying titanium and potential heavy rare earths for defense and maritime markets.
IperionX (NASDAQ: IPX) reported December 31, 2025 quarterly results outlining commercial commissioning, capacity expansion, and U.S. government funding to scale titanium production.
Key points: commercial commissioning complete, ramp to 1,400 tpa targeted in 2027, estimated expansion cost ~US$75 million, and US$47.1 million IBAS funding now obligated.
IperionX (NASDAQ: IPX) received a US$0.3 million prototype purchase order from American Rheinmetall to produce 700 lightweight titanium components for U.S. Army heavy ground combat systems on Jan 22, 2026. The components will be manufactured in the United States using 100% recycled titanium made via IperionX’s HAMR™ and HSPT™ technologies, which the company says lower costs versus conventional routes. Replacing steel parts is expected to reduce component weight by ~40–45%, cutting several hundred kilograms per vehicle depending on configuration. The order could lead to a larger agreement if delivery is successful and is described as supporting U.S. reshoring of strategic titanium supply chains.
IperionX (NASDAQ: IPX) received the final US$4.6 million tranche from the U.S. Department of War’s IBAS program, completing a US$47.1 million award to support scale-up of its Titanium Manufacturing Campus in Virginia.
The funding will support scaling production to up to 1,400 metric tons per year. The U.S. Government also transferred ~290 metric tons of Ti64 titanium scrap to IperionX at no cost, equivalent to ~1.5 years of feedstock at the current full operating capacity of 200 tpa. Prior tranches totalled US$42.5 million; all DoW obligations have now been received.
IperionX (NASDAQ: IPX) announced a project with Carver Pump to prototype critical titanium components for U.S. Navy ship pumps, following an initial purchase order for prototypes dated Dec. 15, 2025. IperionX will use low-cost, domestically produced titanium metal powder from its recently commissioned Titanium Production Facility in Virginia and integrated manufacturing to produce casting replacements.
The project targets a step-change in lead times: conventional cast parts can exceed 12 months, while IperionX expects to produce each component in less than one week. Successful prototyping and testing could enable larger-scale production agreements with Carver Pump and the U.S. Navy.
IperionX (NASDAQ: IPX) responded to a short seller report on 17 November 2025, providing material, verifiable facts about its operations, U.S. government awards, and financial position. The company highlights multiple U.S. Department of War and other federal awards including DPA $12.7M, IBAS $47.1M (with additional tranches of $12.5M and $25M), and a U.S. Army SBIR Phase III IDIQ up to $99M. IperionX says Virginia commissioning increased nameplate capacity from 125 tpa to 200 tpa and a DoW‑cofunded expansion targets ~1,400 tpa by mid‑2027. Cash and funding: $79.2M cash (30 Sep 2025), ~$43M obligated under DoW programs, and ~$97M SBIR funding capacity. The Titan DFS is expected by mid‑2026 and project finance is required for development.
IperionX (NASDAQ: IPX) reported quarterly results for the period ended September 30, 2025, with commercial titanium production online, higher capacity and lower unit costs.
Key facts: nameplate titanium powder capacity rose 60% via process improvements; commissioning of an expansion to 1,400 tpa is planned for mid‑2027; total expansion capital is ~US$75 million, majority funded by a U.S. Department of War IBAS award of US$47.1 million (US$42.5 million obligated to date).
Financials: cash of US$79.2 million at Sept 30, 2025 and a pro‑forma cash position near US$100 million after a private placement of 14 million shares at A$5.00 (A$70 million).